; (B) a review of risks associated with the foreign manufacture of such drugs, ingredients, or devices; and (C) recommendations on how to mitigate any such risks. (b) Standing forum The Secretary of Health and Human Services, in collaboration with the Secretary of Homeland Security, shall establish a standing forum to engage stakeholders, including pharmacists, hospitals, physicians, and pharmaceutical and medical device manufacturers, to mitigate risks identified through the assessment conducted under subsection (a).